Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-009051
Filing Date
2017-05-15
Accepted
2017-05-15 07:51:21
Documents
56
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tlcc20170331_10q.htm 10-Q 617177
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 15597
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 15528
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6907
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6938
  Complete submission text file 0001437749-17-009051.txt   4469468

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS tlcc-20170331.xml EX-101.INS 938867
7 EXHIBIT 101.SCH tlcc-20170331.xsd EX-101.SCH 52765
8 EXHIBIT 101.CAL tlcc-20170331_cal.xml EX-101.CAL 39952
9 EXHIBIT 101.DEF tlcc-20170331_def.xml EX-101.DEF 335431
10 EXHIBIT 101.LAB tlcc-20170331_lab.xml EX-101.LAB 286929
11 EXHIBIT 101.PRE tlcc-20170331_pre.xml EX-101.PRE 354432
Mailing Address 632 BROADWAY SUITE 201 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 201 NEW YORK NY 10012 (212) 651-8500
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

EIN.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55181 | Film No.: 17841107
SIC: 2833 Medicinal Chemicals & Botanical Products